Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Transplantation, enter your email address in the box below.

Journal of Transplantation
Volume 2014 (2014), Article ID 854397, 11 pages
http://dx.doi.org/10.1155/2014/854397
Clinical Study

Risk-Stratified Cardiovascular Screening Including Angiographic and Procedural Outcomes of Percutaneous Coronary Interventions in Renal Transplant Candidates

Julian König,1,2 Martin Möckel,1,3 Eda Mueller,4 Wolfgang Bocksch,1 Seema Baid-Agrawal,2 Nina Babel,2 Ralf Schindler,2 Petra Reinke,2,5 and Peter Nickel2

1Department of Cardiology, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
2Department of Nephrology and Intensive Care, Charité Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany
3Division of Emergency Medicine, Charité Campus Virchow-Klinikum and Mitte, Augustenburger Platz 1, 13353 Berlin, Germany
4Department of Cardiology and Angiology, Charité Campus Mitte, Charitéplatz 1, 10117 Berlin, Germany
5Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charité Campus Virchow-Klinikum, Charite-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

Received 16 January 2014; Revised 8 May 2014; Accepted 12 May 2014; Published 19 June 2014

Academic Editor: Gaetano Ciancio

Copyright © 2014 Julian König et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Wolfe, V. B. Ashby, E. L. Milford et al., “Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant,” The New England Journal of Medicine, vol. 341, no. 23, pp. 1725–1730, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. US Renal Data System: USRDS 2010 Annual Data Report, Altas of ESRD, Transplantation, Fig 7.2, Fig 7,4, Fig 7.12 (Volume 2), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md, USA, http://www.usrds.org/2010/slides/flash/vol2_07_tx_10/aP%20Lite%20Flash/index.html.
  3. U. Frei, J. Noeldeke, V. Machold-Fabrizii et al., “Prospective age-matching in elderly kidney transplant recipients—a 5-year analysis of the eurotransplant senior program,” American Journal of Transplantation, vol. 8, no. 1, pp. 50–57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. R. K. Patel, P. B. Mark, N. Johnston et al., “Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study,” American Journal of Transplantation, vol. 8, no. 8, pp. 1673–1683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. V. S. Stel, P. C. W. van Dijk, J. G. van Manen et al., “Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation,” Nephrology Dialysis Transplantation, vol. 20, no. 12, pp. 2803–2811, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. “Eurotransplant annual report 2009 Figure 3.2,” http://www.eurotransplant.org/cms/mediaobject.php?file=ar_2009.pdf.
  7. “European Best Practice Guidelines for Renal Transplantation (Part 1). Produced by the EBPG Expert Group on Renal Transplantation. Section I: evaluation, selection and preparation of the potential transplant recipient,” Nephrology Dialysis Transplantation, vol. 15, supplement 7, p. 3, 2000.
  8. B. L. Kasiske, C. B. Cangro, S. Hariharan et al., “The evaluation of renal transplant candidates: clinical practice guidelines,” American Journal of Transplantation, vol. 1, no. 2, pp. 5–95, 2001. View at Google Scholar · View at Scopus
  9. National Kidney Foundation, “K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients,” American Journal of Kidney Diseases, vol. 45, supplement 3, pp. S1–153, 2005. View at Google Scholar
  10. K. L. Lentine, S. P. Costa, M. R. Weir et al., “Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation,” Journal of the American College of Cardiology, vol. 60, no. 5, pp. 434–480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. E. O. McFalls, H. B. Ward, T. E. Moritz et al., “Coronary-artery revascularization before elective major vascular surgery,” The New England Journal of Medicine, vol. 351, no. 27, pp. 2795–2804, 2004. View at Google Scholar
  12. W. E. Boden, R. A. O'Rourke, K. K. Teo et al., “Optimal medical therapy with or without PCI for stable coronary disease,” The New England Journal of Medicine, vol. 356, no. 15, pp. 1503–1516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Patel, G. J. Dehmer, J. W. Hirshfeld, P. K. Smith, and J. A. Spertus, “ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography,” Journal of the American College of Cardiology, vol. 59, no. 9, pp. 857–881, 2012. View at Publisher · View at Google Scholar
  14. A. P. Kappetein, T. E. Feldman, M. J. MacK et al., “Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial,” European Heart Journal, vol. 32, no. 17, pp. 2125–2134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. S.-E. Hassani, W. W. Chu, R. M. Wolfram et al., “Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients,” Journal of Invasive Cardiology, vol. 18, no. 6, pp. 273–277, 2006. View at Google Scholar · View at Scopus
  16. J. H. Wang and B. L. Kasiske, “Screening and management of pretransplant cardiovascular disease,” Current Opinion in Nephrology and Hypertension, vol. 19, no. 6, pp. 586–591, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Bocksch, S. Fateh-Moghadam, E. Mueller, S. Huehns, J. Waigand, and R. Dietz, “Percutaneous coronary intervention in patients with end-stage renal disease,” Kidney and Blood Pressure Research, vol. 28, no. 5-6, pp. 275–279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Ashrith, M. A. Elayda, and J. M. Wilson, “Revascularization options in patients with chronic kidney disease,” Texas Heart Institute Journal, vol. 37, no. 1, pp. 9–18, 2010. View at Google Scholar · View at Scopus
  19. J. D. Schold, A. R. Sehgal, T. R. Srinivas, E. D. Poggio, S. D. Navaneethan, and B. Kaplan, “Marked variation of the association of esrd duration before and after wait listing on kidney transplant outcomes,” American Journal of Transplantation, vol. 10, no. 9, pp. 2008–2016, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Friedman, R. T. Palac, D. M. Zlotnick, M. C. Chobanian, and S. P. Costa, “A call to action: variability in guidelines for cardiacevaluation before renal transplantation,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 1185–1191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. J. G. De Lima, E. Sabbaga, M. L. C. Vieira et al., “Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing,” Hypertension, vol. 42, no. 3, pp. 263–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. S. Gill, I. Ma, D. Landsberg, N. Johnson, and A. Levin, “Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation,” Journal of the American Society of Nephrology, vol. 16, no. 3, pp. 808–816, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. B. L. Kasiske, M. A. Malik, and C. A. Herzog, “Risk-stratified screening for ischemic heart disease in kidney transplant candidates,” Transplantation, vol. 80, no. 6, pp. 815–820, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. L. H. W. Gowdak, F. J. de Paula, L. A. M. César et al., “Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates,” Nephrology Dialysis Transplantation, vol. 22, no. 5, pp. 1456–1461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. F. G. Hage, S. Smalheiser, G. J. Zoghbi et al., “Predictors of Survival in Patients With End-Stage Renal Disease Evaluated for Kidney Transplantation,” American Journal of Cardiology, vol. 100, no. 6, pp. 1020–1025, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. L. H. W. Gowdak, F. J. De Paula, L. A. M. César et al., “Screening for significant coronary artery disease in high-risk renal transplant candidates,” Coronary Artery Disease, vol. 18, no. 7, pp. 553–558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. D. G. Jones, A. M. Taylor, S. A. Enkiri et al., “Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation,” American Journal of Transplantation, vol. 9, no. 8, pp. 1846–1852, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. K. L. Lentine, M. A. Schnitzler, D. C. Brennan et al., “Cardiac evaluation before kidney transplantation: a practice patterns analysis in medicare-insured dialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 4, pp. 1115–1124, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. J. G. De Lima, L. H. W. Gowdak, F. J. De Paula et al., “Treatment of coronary artery disease in hemodialysis patients evaluated for transplant—a registry study,” Transplantation, vol. 89, no. 7, pp. 845–850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Leonardi, M. Tamagnone, M. Ferro et al., “Assessment of cardiovascular risk in waiting-listed renal transplant patients: a single center experience in 558 cases,” Clinical Transplantation, vol. 23, no. 5, pp. 653–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Aalten, E. K. Hoogeveen, J. I. Roodnat et al., “Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death,” Transplant International, vol. 21, no. 10, pp. 985–991, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Aalten, S. A. Peeters, M. J. Van Der Vlugt, and A. J. Hoitsma, “Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial?” Nephrology Dialysis Transplantation, vol. 26, no. 9, pp. 3006–3012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. S. C. Smith Jr., T. E. Feldman, J. W. Hirshfeld et al., “ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention),” Circulation, vol. 113, no. 7, pp. e166–e286, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Kobayashi, J. De Gregorio, N. Kobayashi et al., “Stented segment length as an independent predictor of restenosis,” Journal of the American College of Cardiology, vol. 34, no. 3, pp. 651–659, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. P. A. Lemos, A. Hoye, D. Goedhart et al., “Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study,” Circulation, vol. 109, no. 11, pp. 1366–1370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Gruberg and R. Beyar, “End-stage renal disease and drug-eluting stents: one small step forward,” Journal of Invasive Cardiology, vol. 18, no. 9, pp. 409–410, 2006. View at Google Scholar · View at Scopus
  37. H. Ishii, T. Toriyama, T. Aoyama et al., “Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients,” Circulation Journal, vol. 76, no. 7, pp. 1609–1615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Wijns, P. Kolh, N. Danchin et al., “Guidelines on myocardial revascularization. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI),” European Heart Journal, vol. 31, no. 20, pp. 2501–2555, 2010. View at Publisher · View at Google Scholar
  39. P. J. M. Best, R. Lennon, H. H. Ting et al., “The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions,” Journal of the American College of Cardiology, vol. 39, no. 7, pp. 1113–1119, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. R. R. Azar, R. Prpic, K. K. L. Ho et al., “Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting,” American Journal of Cardiology, vol. 86, no. 5, pp. 485–489, 2000. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Borentain, C. Le Feuvre, G. Helft et al., “Long-term outcome after coronary angioplasty in renal transplant and hemodialysis patients,” Journal of Interventional Cardiology, vol. 18, no. 5, pp. 331–337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Le Feuvre, G. Dambrin, G. Helft et al., “Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting,” Heart, vol. 85, no. 5, pp. 556–560, 2001. View at Google Scholar · View at Scopus
  43. C. Le Feuvre, G. Dambrin, G. Helft et al., “Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients,” American Journal of Cardiology, vol. 85, no. 11, pp. 1365–1368, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. T. I. Chang, D. Shilane, D. S. Kazi, M. E. Montez-Rath, M. A. Hlatky, and W. C. Winkelmayer, “Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2042–2049, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. E. Tsagalou, A. Chieffo, I. Iakovou et al., “Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery,” Journal of the American College of Cardiology, vol. 45, no. 10, pp. 1570–1573, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. N. Kumar, C. S. R. Baker, K. Chan et al., “Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 8, pp. 1912–1919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. B. L. Kasiske, A. K. Israni, J. J. Snyder, and A. Camarena, “Design considerations and feasibility for a clinical trial to examine coronary screening before kidney transplantation (COST),” American Journal of Kidney Diseases, vol. 57, no. 6, pp. 908–916, 2011. View at Publisher · View at Google Scholar · View at Scopus